EcoDrugPlus

Leukotriene B4 Receptor 2a

Ensembl ID : ENSCHAG00000007799
Gene Symbol: LTB4R2A
1 Cross references
159 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSCHAG00000023638
Gene Symbol: LTB4R2B
1 Cross references
167 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSCHAG00000027737
Gene Symbol: KDM1A
1 Cross references
214 Possible Orthologues:

Lysyl Oxidase-Like 2a

Ensembl ID : ENSCHAG00000004948
Gene Symbol: LOXL2A
1 Cross references
210 Possible Orthologues:

Lysyl Oxidase-Like 2b

Ensembl ID : ENSCHAG00000017766
Gene Symbol: LOXL2B
1 Cross references
213 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSCHAG00000013705
Gene Symbol: MIF
3 Cross references
235 Possible Orthologues:

Mast/stem Cell Growth Factor Receptor Kita-Like

Ensembl ID : ENSCHAG00000012047
Gene Symbol: LOC105908497
3 Cross references
208 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSCHAG00000020846
Gene Symbol: MMP1
1 Cross references
325 Possible Orthologues:

Matrix Metallopeptidase 14b (Membrane-Inserted)

Ensembl ID : ENSCHAG00000002635
Gene Symbol: MMP14B
1 Cross references
198 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSCHAG00000001051
Gene Symbol: MMP2
3 Cross references
210 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSCHAG00000015229
Gene Symbol: MMP9
1 Cross references
216 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSCHAG00000021474
Gene Symbol: LOC105895553
3 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).